STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS-Reference-Cited by-同舟云学术

STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS

Published:2021-06-01 Issue:1 Volume:71 Page:177-187
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Andersen Morten N.^ORCID,Andersen Niels F.,Lauridsen Kristina L.,Etzerodt Anders,Sorensen Boe S.,Abildgaard Niels,Plesner Trine,Hokland Marianne,Møller Holger J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-02952-1.pdf

Reference47 articles.

1. Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538–e548. https://doi.org/10.1016/S1470-2045(14)70442-5

2. Landgren O, Kyle RA, Pfeiffer RM et al (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113:5412–5417. https://doi.org/10.1182/blood-2008-12-194241

3. Bladé J, Rosinol L, Cibeira MT, de Larrea CF (2008) Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Leukemia 22:1651–1657. https://doi.org/10.1038/leu.2008.203

4. Zhao S, Choi M, Heuck C et al (2014) Serial exome analysis of disease progression in premalignant gammopathies. Leukemia 28:1548–1552. https://doi.org/10.1038/leu.2014.59

5. Dhodapkar MV (2016) MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood 128:2599–2606. https://doi.org/10.1182/blood-2016-09-692954

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy;Cell Biochemistry and Biophysics;2024-06-17

2. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways;European Journal of Pharmacology;2023-02

3. Macrophage scavenger receptors: Tumor support and tumor inhibition;Frontiers in Oncology;2023-01-06

4. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches;International Journal of Molecular Sciences;2022-05-08

5. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma;Journal of Hematology & Oncology;2022-02-16